ARKEMA (AKE.PA)

FR0010313833 - Common Stock

72.15  +2 (+2.85%)

Fundamental Rating

5

AKE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 62 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE scores decently on growth, while it is valued quite cheap. This could make an interesting combination. AKE also has an excellent dividend rating.



4

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
AKE had a positive operating cash flow in the past year.
AKE had positive earnings in each of the past 5 years.
Each year in the past 5 years AKE had a positive operating cash flow.

1.2 Ratios

AKE has a Return On Assets (2.36%) which is in line with its industry peers.
AKE has a Return On Equity (4.80%) which is comparable to the rest of the industry.
AKE has a Return On Invested Capital (4.63%) which is in line with its industry peers.
AKE had an Average Return On Invested Capital over the past 3 years of 7.27%. This is in line with the industry average of 6.87%.
Industry RankSector Rank
ROA 2.36%
ROE 4.8%
ROIC 4.63%
ROA(3y)6.77%
ROA(5y)5.52%
ROE(3y)13.03%
ROE(5y)10.85%
ROIC(3y)7.27%
ROIC(5y)6.75%

1.3 Margins

AKE has a Profit Margin of 3.64%. This is in the better half of the industry: AKE outperforms 60.34% of its industry peers.
In the last couple of years the Profit Margin of AKE has declined.
AKE has a Operating Margin of 7.95%. This is in the better half of the industry: AKE outperforms 68.97% of its industry peers.
AKE's Operating Margin has declined in the last couple of years.
AKE's Gross Margin of 20.45% is on the low side compared to the rest of the industry. AKE is outperformed by 67.24% of its industry peers.
AKE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.95%
PM (TTM) 3.64%
GM 20.45%
OM growth 3Y3.14%
OM growth 5Y-7%
PM growth 3Y3.1%
PM growth 5Y-11.18%
GM growth 3Y1.61%
GM growth 5Y-1.66%

5

2. Health

2.1 Basic Checks

AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
AKE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for AKE has been reduced compared to 5 years ago.
Compared to 1 year ago, AKE has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 1.91 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.91, AKE perfoms like the industry average, outperforming 43.10% of the companies in the same industry.
The Debt to FCF ratio of AKE is 9.10, which is on the high side as it means it would take AKE, 9.10 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 9.10, AKE is doing good in the industry, outperforming 65.52% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that AKE is not too dependend on debt financing.
AKE has a Debt to Equity ratio (0.49) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.1
Altman-Z 1.91
ROIC/WACC0.92
WACC5.02%

2.3 Liquidity

A Current Ratio of 2.11 indicates that AKE has no problem at all paying its short term obligations.
AKE has a Current ratio of 2.11. This is in the better half of the industry: AKE outperforms 65.52% of its industry peers.
AKE has a Quick Ratio of 1.54. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AKE (1.54) is better than 74.14% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.54

4

3. Growth

3.1 Past

AKE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.42%.
Measured over the past years, AKE shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.78% on average per year.
Looking at the last year, AKE shows a decrease in Revenue. The Revenue has decreased by -3.12% in the last year.
AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.54% yearly.
EPS 1Y (TTM)-1.42%
EPS 3Y19.67%
EPS 5Y-0.78%
EPS Q2Q%-5.46%
Revenue 1Y (TTM)-3.12%
Revenue growth 3Y6.46%
Revenue growth 5Y1.54%
Sales Q2Q%2.92%

3.2 Future

Based on estimates for the next years, AKE will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.27% on average per year.
Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 4.04% on average per year.
EPS Next Y1.7%
EPS Next 2Y7.61%
EPS Next 3Y8.48%
EPS Next 5Y9.27%
Revenue Next Year1.05%
Revenue Next 2Y3.01%
Revenue Next 3Y3.4%
Revenue Next 5Y4.04%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

7

4. Valuation

4.1 Price/Earnings Ratio

AKE is valuated reasonably with a Price/Earnings ratio of 8.63.
AKE's Price/Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 93.10% of the companies in the same industry.
AKE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.40.
AKE is valuated cheaply with a Price/Forward Earnings ratio of 7.13.
Based on the Price/Forward Earnings ratio, AKE is valued cheaper than 96.55% of the companies in the same industry.
AKE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.67.
Industry RankSector Rank
PE 8.63
Fwd PE 7.13

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKE is valued cheaply inside the industry as 87.93% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 84.48% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.34
EV/EBITDA 4.99

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.07
PEG (5Y)N/A
EPS Next 2Y7.61%
EPS Next 3Y8.48%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.89%, AKE is a good candidate for dividend investing.
AKE's Dividend Yield is rather good when compared to the industry average which is at 4.00. AKE pays more dividend than 81.03% of the companies in the same industry.
AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 4.89%

5.2 History

On average, the dividend of AKE grows each year by 7.88%, which is quite nice.
Dividend Growth(5Y)7.88%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

AKE pays out 75.43% of its income as dividend. This is not a sustainable payout ratio.
The dividend of AKE is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP75.43%
EPS Next 2Y7.61%
EPS Next 3Y8.48%

ARKEMA

EPA:AKE (1/6/2025, 7:00:00 PM)

72.15

+2 (+2.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)N/A N/A
Inst Owners54.6%
Inst Owner ChangeN/A
Ins Owners0.54%
Ins Owner ChangeN/A
Market Cap5.49B
Analysts81.82
Price Target109.2 (51.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.89%
Dividend Growth(5Y)7.88%
DP75.43%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.35%
Min EPS beat(2)-1.73%
Max EPS beat(2)8.44%
EPS beat(4)2
Avg EPS beat(4)-2.2%
Min EPS beat(4)-24.41%
Max EPS beat(4)8.93%
EPS beat(8)6
Avg EPS beat(8)4.42%
EPS beat(12)10
Avg EPS beat(12)14.87%
EPS beat(16)14
Avg EPS beat(16)17.92%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)3.26%
Revenue beat(4)2
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)3.26%
Revenue beat(8)3
Avg Revenue beat(8)-1.24%
Revenue beat(12)7
Avg Revenue beat(12)0.81%
Revenue beat(16)11
Avg Revenue beat(16)1.68%
PT rev (1m)-0.72%
PT rev (3m)-1.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE 8.63
Fwd PE 7.13
P/S 0.58
P/FCF 11.34
P/OCF 4.67
P/B 0.76
P/tB 2.95
EV/EBITDA 4.99
EPS(TTM)8.36
EY11.59%
EPS(NY)10.12
Fwd EY14.03%
FCF(TTM)6.36
FCFY8.82%
OCF(TTM)15.46
OCFY21.43%
SpS124.81
BVpS94.73
TBVpS24.49
PEG (NY)5.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 4.8%
ROCE 6.18%
ROIC 4.63%
ROICexc 5.54%
ROICexgc 11.64%
OM 7.95%
PM (TTM) 3.64%
GM 20.45%
FCFM 5.1%
ROA(3y)6.77%
ROA(5y)5.52%
ROE(3y)13.03%
ROE(5y)10.85%
ROIC(3y)7.27%
ROIC(5y)6.75%
ROICexc(3y)8.88%
ROICexc(5y)8.2%
ROICexgc(3y)16.83%
ROICexgc(5y)15.32%
ROCE(3y)9.93%
ROCE(5y)9.15%
ROICexcg growth 3Y0.94%
ROICexcg growth 5Y-10.3%
ROICexc growth 3Y-2.69%
ROICexc growth 5Y-13.4%
OM growth 3Y3.14%
OM growth 5Y-7%
PM growth 3Y3.1%
PM growth 5Y-11.18%
GM growth 3Y1.61%
GM growth 5Y-1.66%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.1
Debt/EBITDA 2.29
Cap/Depr 87.82%
Cap/Sales 7.29%
Interest Coverage 47.19
Cash Conversion 76.22%
Profit Quality 139.88%
Current Ratio 2.11
Quick Ratio 1.54
Altman-Z 1.91
F-Score5
WACC5.02%
ROIC/WACC0.92
Cap/Depr(3y)97.02%
Cap/Depr(5y)94.73%
Cap/Sales(3y)7.15%
Cap/Sales(5y)7.34%
Profit Quality(3y)80.08%
Profit Quality(5y)107.63%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.42%
EPS 3Y19.67%
EPS 5Y-0.78%
EPS Q2Q%-5.46%
EPS Next Y1.7%
EPS Next 2Y7.61%
EPS Next 3Y8.48%
EPS Next 5Y9.27%
Revenue 1Y (TTM)-3.12%
Revenue growth 3Y6.46%
Revenue growth 5Y1.54%
Sales Q2Q%2.92%
Revenue Next Year1.05%
Revenue Next 2Y3.01%
Revenue Next 3Y3.4%
Revenue Next 5Y4.04%
EBIT growth 1Y-0.4%
EBIT growth 3Y9.8%
EBIT growth 5Y-5.57%
EBIT Next Year73.05%
EBIT Next 3Y25.84%
EBIT Next 5Y18.23%
FCF growth 1Y-15.24%
FCF growth 3Y5.21%
FCF growth 5Y6.28%
OCF growth 1Y-12.69%
OCF growth 3Y4.49%
OCF growth 5Y4.33%